JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

JNJ

237.77

+0.97%↑

UNH

267.75

-2.61%↓

TMO

552.88

-2.86%↓

ABT

109.14

+0.11%↑

ISRG

478.81

+0.76%↑

Search

Quanterix Corp

Deschisă

SectorSănătate

6.21 -0.32

Rezumat

Modificarea prețului

24h

Curent

Minim

6.06

Maxim

6.38

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+16.28% upside

Dividende

By Dow Jones

Următoarele câștiguri

16 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

66M

304M

Deschiderea anterioară

6.53

Închiderea anterioară

6.21

Sentimentul știrilor

By Acuity

50%

50%

151 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 feb. 2026, 00:00 UTC

Acțiuni populare

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 feb. 2026, 22:55 UTC

Câștiguri

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 feb. 2026, 21:44 UTC

Câștiguri

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 feb. 2026, 21:39 UTC

Câștiguri

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 feb. 2026, 00:00 UTC

Câștiguri

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 feb. 2026, 00:00 UTC

Câștiguri

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 feb. 2026, 23:45 UTC

Câștiguri

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 feb. 2026, 23:32 UTC

Market Talk

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 feb. 2026, 22:59 UTC

Achiziții, Fuziuni, Preluări

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 feb. 2026, 22:30 UTC

Câștiguri

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 feb. 2026, 22:30 UTC

Câștiguri

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 feb. 2026, 22:21 UTC

Câștiguri

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 feb. 2026, 22:17 UTC

Market Talk

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 feb. 2026, 22:15 UTC

Market Talk

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 feb. 2026, 22:00 UTC

Market Talk

ESG Roundup: Market Talk

4 feb. 2026, 21:53 UTC

Câștiguri

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 feb. 2026, 21:51 UTC

Câștiguri

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 feb. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

4 feb. 2026, 21:50 UTC

Market Talk
Câștiguri

Auto & Transport Roundup: Market Talk

4 feb. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

4 feb. 2026, 21:45 UTC

Câștiguri

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 feb. 2026, 21:44 UTC

Câștiguri

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 feb. 2026, 21:43 UTC

Câștiguri

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 feb. 2026, 21:41 UTC

Câștiguri

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 feb. 2026, 21:36 UTC

Market Talk

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 feb. 2026, 21:30 UTC

Câștiguri

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 feb. 2026, 21:30 UTC

Câștiguri

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 feb. 2026, 21:30 UTC

Câștiguri

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

16.28% sus

Prognoză pe 12 luni

Medie 7.5 USD  16.28%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

151 / 352 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat